Kepos Capital LP Regenxbio Inc. Transaction History

Kepos Capital LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 13, 2019	SELL	$42.0 - $59.29 $2.24 Million - $3.16 Million	-53,251 Closed	0 $0
Q1 2019 May 13, 2019	SELL	$40.82 - $62.45 $351,827 - $538,256	-8,619 Reduced 13.93%	53,251 $3.05 Million
Q4 2018 Feb 13, 2019	SELL	$39.11 - $75.15 $250,851 - $482,012	-6,414 Reduced 9.39%	61,870 $2.6 Million
Q3 2018 Nov 13, 2018	BUY	$65.0 - $82.15 $4.44 Million - $5.61 Million	68,284 New	68,284 $5.16 Million

195

42.9M

104K

478K

Ticker RGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,230,000
Market Cap $325M
Description
REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...

Get notified when there are updates to the investment portfolio of Kepos Capital LP, based on Form 13F filings with the SEC.

Stay updated on Kepos Capital LP with notifications on news.